Advanced search
Publication Cover
Acta Cardiologica Volume 62, 2007 - Issue 5
Submit an article Journal homepage
8
Views
1
CrossRef citations to date
0
Altmetric
Articles

The relationship between Helicobacter pylori IgG titre and coronary

Ibrahim OzdogruDepartment of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey.Correspondence[email protected]
,
Nihat KalayDepartment of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey.
,
Ali DoganDepartment of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey.
,
Mehmet T. InancDepartment of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey.
,
Mehmet Gungor KayaDepartment of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey.
,
Ramazan TopsakalDepartment of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey.
,
Ibrahim GulDepartment of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey.
,
Ilker KutukogluDepartment of Microbiology, Erciyes University School of Medicine, Kayseri, Turkey.
,
Huseyin KilicDepartment of Microbiology, Erciyes University School of Medicine, Kayseri, Turkey.
&
Namik K. EryolDepartment of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey.
 show all
Pages 501-505 | Received 10 Jan 2007, Accepted 12 Jun 2007, Published online: 23 May 2017

References

  • Tiong AY, Brieger D. Inflammation and coronary artery dis-ease. Am Heart J2005; 150: 11-8.
  • Dittrich R, Dragonas C, Mueller A, Maltaris T, Rupp J, Beckmann MW, Maass M. Endothelial Chlamydia pneu-moniae infection promotes oxidation of LDL. Biochem Bio-phys Res Commun 2004; 319: 501–5.
  • Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silber-shatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837–47.
  • Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 2005; 6: 21–9.
  • Muhlestein JB, Anderson JL. Chronic infection and coro-nary artery disease. Cardiol Clin 2003; 21: 333–62.
  • Romano S, Penco M, Fratini S, Di Pietro M, Sessa R, Del Piano M, Fedele F, Dagianti A. Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability. Int J Cardiol 2004; 95: 95–9.
  • Koenig W, Rothenbacher D, Hoffmeister A, Miller M, Bode G, Adler G, Hombach V, Marz W, Pepys MB, Brenner H. Infection with Helicobacter pylori is not a major indepen-dent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation 1999; 100: 2326–31.
  • Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, Elmer SP. Evaluation of C-reactive protein, an inflamma-tory marker, and infectious serology as risk factors for coro-nary artery disease and myocardial infarction. J Am Coll Cardiol 1998; 32: 35–41.
  • Regustrom J, Jovinge S, Bavenholm P, Ericsson CG, De Faire U, Hamsten A, Hellenius ML, Nilsson J, Tornvall P. Heli-cobacter pylori seropositivity is not associated with inflam-matory parameters, lipid concentrations and degree of coro-nary artery disease. J Intern Med 1998; 243: 109–13.
  • Grabczewska Z, Nartowicz E, Kubica J, Rosc D. Endothe-lial function parameters in patients with unstable angina and infection with Helicobacter pylori and Chlamydia pneumo-niae. Eur J Intern Med 2006; 17: 339–42.
  • Kaplan M, Yavuz SS, Cinar B, Koksal V, Kut MS, Yapici F, Gercekoglu H, Demirtas MM. Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis 2006; 10: 116–23.
  • Radke PW, Merkelbach-Bruse S, Messmer BJ, vom Dahl J, Dörge H, Naami A, Vogel G, Handt S, Hanrath P. Infectious agents in coronary lesions obtained by endatherectomy: pat-tern of distribution, coinfection, and clinical findings. Coron Artery Dis 2001; 12: 1–6.
  • Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Car-diology Committee for the redefinition of myocardial infarc-tion. J Am Coll Cardiol 2000; 36: 959–69.
  • Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410–4.
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972; 18: 499–502.
  • Graham DY, Evans DJ Jr, Peacock J, Baker JT, Schrier WH. Comparison of rapid serological tests (FlexSure HP and QuickVue) with conventional ELISA for detection of Helicobacter pylori infection. Am J Gastroenterol 1996; 91: 942–8.
  • Marchildon PA, Ciota LM, Zamaniyan FZ, Peacock JS, Graham DY. Evaluation of three commercial enzyme immunoassays compared with the 13C urea breath test for detection of Helicobacter pylori infection. J Clin Microbiol 1996; 34: 1147–52.
  • Evans DJ Jr, Evans DG, Graham DY, Klein PD. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 1989; 96: 1004–8.
  • Gensini GG. A more meaningful scoring system for deter-mining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606–7.
  • Enbergs A, Burger R, Reinecke H, Borggrefe M, Breithardt G, Kerber S. Prevalence of coronary artery disease in a gen-eral population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J2000; 21: 45-52.
  • Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk fac-tors. Am Heart J1990; 119: 1262-7.
  • Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. Br Med J1998; 316: 1130-2.
  • Tsai CJ, Huang TY. Relation of Helicobacter pylori infec-tion and angiographically demonstrated coronary artery dis-ease. Dig Dis Sci 2000; 45: 1227–32.
  • Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong Y, Kishi R. Relationship of Helicobacter pylori infection to arterial stiffness in Japanese subjects Hypertens Res 2005; 28: 283–92.
  • Kinjo K, Sato H, Nakatani D, Mizuno H, Shimizu M, Hishida E, Ezumi A, Hoshida S, Koretsune Y, Hon M; Osaka Acute Coronary Insufficiency Study (OACIS) Group. Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocar-dial infarction. Circ J2002; 66: 805-10.
  • Osawa H, Kawakami M, Fujii M, Kubo N, Iwanaka H, Yamamoto W, Saitoh M, Yaginuma T, Sugano K. Heli-cobacter pylori infection and coronary heart disease in Japanese patients. Cardiology 2001; 95: 14–9.
  • Zhu J, Quyyumi AA, Muhlestein JB, Nieto FJ, Horne BD, Zalles-Ganley A, Anderson JL, Epstein SE. Lack of asso-ciation of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am J Cardiol 2002; 89: 155–8.
  • Kahan T, Lundman P, Olsson G, Wendt M. Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction. Coron Artery Dis 2000; 11: 523–6.
  • Hara K, Morita Y, Kamihata H, Iwasaka T, Takahashi H. Evidence for infection with Helicobacter pylori in patients with acute myocardial infarction. Clin Chim Acta 2001; 313: 87–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.